Clal Biotechnology reported ILS25.96M in Loan Capital for its fiscal quarter ending in December of 2023.


Loan Capital Change Date
Clal Biotechnology ILS 25.96M 18.48M Dec/2023
Compugen USD 0 0 Dec/2024
Life Technologies USD 602K 285K Jun/2025
RedHill Biopharma USD 190K 0 Jun/2024